CAS 865783-99-9

Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate)

CAS: 865783-99-9

Formel: C₁₉H₂₃O₁₀PS

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 474.4187

Ref: IN-DA00GU5H

(E)-2-Methoxy-5-(((2,4,6-Trimethoxystyryl)Sulfonyl)Methyl)Phenyl Dihydrogen Phosphate

CAS: 865783-99-9

(E)-2-Methoxy-5-(((2,4,6-Trimethoxystyryl)Sulfonyl)Methyl)Phenyl Dihydrogen Phosphate

Reinheit: 98%

Molekulargewicht: 474.42g/mol

Ref: 54-OR1022887

Briciclib

CAS: 865783-99-9

Briciclib

Reinheit: ≥98%

Molekulargewicht: 474.42g/mol

Ref: 54-BUP08232

Briciclib

CAS: 865783-99-9

Briciclib (ON 014185) is a small molecule that suppresses cyclin D1 accumulation in Y cells.

Formel: C₁₉H₂₃O₁₀PS

Reinheit: 98% - 99.84%

Farbe und Form: Solid

Molekulargewicht: 474.42

Ref: TM-T3207

Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate)

CAS: 865783-99-9

Reinheit: ≥99%

Molekulargewicht: 474.4200134

Ref: 10-F863783

Briciclib

CAS: 865783-99-9

Briciclib is a quinoline derivative that is used for the treatment of cancer. It inhibits the translation of RNA into protein by binding to eukaryotic initiation factor 4A (eIF4A), which blocks cap-dependent translation. Briciclib has been shown to have anticancer activity in both cell and animal models. This drug also has diagnostic applications, including diagnostic agents for cancer cells.

Formel: C₁₉H₂₃O₁₀PS

Reinheit: Min. 95%

Molekulargewicht: 474.42 g/mol

Ref: 3D-QJB78399